Cargando…
Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values
BACKGROUND: Assessing the cost-effectiveness of treatments in rheumatoid arthritis (RA) is of growing importance due to the chronic nature of the disease, rising treatment costs, and budget-constrained health care systems. This analysis assesses the cost-effectiveness of modified-release (MR) predni...
Autores principales: | Dunlop, William, Iqbal, Itrat, Khan, Ifty, Ouwens, Mario, Heron, Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816994/ https://www.ncbi.nlm.nih.gov/pubmed/24204166 http://dx.doi.org/10.2147/CEOR.S47867 |
Ejemplares similares
-
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone
por: Alten, R, et al.
Publicado: (2015) -
Impact of morning stiffness on working behaviour and performance in people with rheumatoid arthritis
por: Mattila, Kalle, et al.
Publicado: (2014) -
Psychometric properties of morning joint stiffness duration and severity measures in patients with moderately to severely active rheumatoid arthritis
por: Bacci, Elizabeth D., et al.
Publicado: (2017) -
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
por: Krasselt, Marco, et al.
Publicado: (2016) -
Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study
por: Dikranian, Ara H., et al.
Publicado: (2017)